FTSE 100 Falls Amid Corporate Uncertainties and BoE Rate Decision

The FTSE 100 slipped 0.2% as investors processed mixed corporate results and awaited the Bank of England's rate decision. Aerospace and defense stocks led declines, and Hikma Pharmaceuticals fell sharply. The dollar's weakness boosted sterling, adding pressure on exports. Meanwhile, the FTSE 250 rose, driven by Harbour Energy's surge.


Devdiscourse News Desk | Updated: 07-08-2025 15:45 IST | Created: 07-08-2025 15:45 IST
FTSE 100 Falls Amid Corporate Uncertainties and BoE Rate Decision
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The FTSE 100 index experienced a 0.2% decline on Thursday as investors grappled with mixed corporate earnings and awaited a critical interest rate decision from the Bank of England. The central bank is expected to cut rates for the fifth time in a year, though inflation concerns may influence further monetary policy.

Aerospace and defense sectors saw a notable 2.6% drop, impacted by Rheinmetall's underwhelming quarterly results, affecting peers like Britain's BAE Systems and Babcock. Hikma Pharmaceuticals faced a significant 6.7% drop due to a negative margin outlook, while healthcare stocks collectively fell by 1.1%.

Compounding these pressures, President Trump announced incremental tariffs on pharmaceutical imports. In contrast, the FTSE 250 rose by 0.3%, buoyed by Harbour Energy's forecast increase. InterContinental Hotels Group reported strong profits, while WPP's share price hit a significant low.

(With inputs from agencies.)

Give Feedback